chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Narrative:  03/29, Pfizer, dose #1 04/16, Pfizer, dose #2 07/21 CXR impression: No evidence of an acute process. Clear lungs. 10/04 pt cc:cough, fatigue, fever, headache, loss of taste or smell, myalgias, dyspnea, sore throat exposure: unknown 08/06 COVID swab, result: not detected 10/07 COVID swab, result: not detected 10/13 SARS-COV-2 Variant Sequencing resut: pending 10/13 COVID swab, result: detected 10/15 pt admit ED cc: "intermittent coughing and some bilateral upper (non mid line) back pain (thoracic region, not over where his kidneys are)" dx: COVID 19 LOS: 1 day 10/15 procalcitonin: 0.10 10/15 ddimer: 0.50 10/15 CXR impression: New left lung base opacity, suspicious for pneumonia. 10/15 CTA PE impression: Impression:1. No CT evidence of a large central pulmonary embolism. 2. Diffuse ground glass opacities involving the bilateral lower lobes and right upper lobe. Finding may be consistent with the patient's positive COVID status. 3. Atherosclerosis. 4. Hepatic steatosis. Total DLP (mGy*cm): 424.4 10/19 clinically resolved 10/28 10/28 COVID swab, result: detected
54yo male w/suspected Penile Mondor's disease (PMD) 2 weeks after receiving j&j vaccine 4.30.21  Penile Mondor's disease (PMD) is a benign, self-limiting  thrombophlebitis of the superficial dorsal vein of the penis.
Employee received COVID vaccine # 1.  Denies any previous reaction to vaccines.  0905-Employee was close to end of 15 min monitoring, when she began to have left arm pain where the vaccine was given stating that she "felt like her arm was swelling", had dizziness, shortness of breath, flushing of face, feeling like her feet were swelling  and overall not feeling well.  Medical Response Team called, 50 mg of Benadryl given po. Respiratory Therapy noted wheezing in posterior lungs, 2 puffs of Albuterol inhaler given. Vital signs as follows: 183/91 pulse 102-111, 96-98% on RA and respirations 22. EE was taken to ED and given steroids and was monitored in ED.
Dizziness; slept the whole day; Headache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 63 year-old male patient received bnt162b2 (BNT162B2), administration date 23Apr2021 (Batch/Lot number: unknown) at the age of 63 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Palpitations" (unspecified if ongoing), notes: He has palpitations; "Diabetes" (unspecified if ongoing), notes: He has sugar diabetes and a stent in in his heart; "Stent placement" (unspecified if ongoing), notes: He has sugar diabetes and a stent in in his heart. The patient's concomitant medications were not reported.  The following information was reported: DIZZINESS (non-serious) with onset 23Apr2021, outcome "recovered" (Apr2021), described as "Dizziness"; HEADACHE (non-serious) with onset Apr2021, outcome "unknown", described as "Headache"; SOMNOLENCE (non-serious) with onset 23Apr2021, outcome "recovered" (Apr2021), described as "slept the whole day". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
High fever ongoing 16 hours now. Headache, shaking, muscle pain, vomiting
Information has been received from a registered nurse concerning an approximately 3 or 4 year old male who (at 12-15 months of age) in approximately 1995 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). In approximately 1998 (2-3 years later) the patient was diagnosed with chickenpox. No other information was available. Unspecified medical attention was sought in the physician's office. The outcome was reported as recovered. There was no product quality complaint. Additional information is expected.
Patient was given Pfizer Dose 1 after receiving Moderna Dose 1 on 6/30/2021.  The pt did not receive Moderna Dose 2 at any point after the first dose
Client presented for covid vaccination.  J & J vaccine was being administered at this site. Client put age "18" on the registration form.  Nurse verified age by circling age per our process and verbally asked client who stated "18" and vaccinated client.  Data entry discovered that client's birthdate was 4/11/2003 so he was actually one day shy of being 18.
This spontaneous report as received from an Immunization Specialist referring to a 23 year old male patient. Information about the patient's medical history, concurrent conditions and concomitant medication was not reported.  On 08-MAY-2017, the patient was vaccinated with GARDASIL 9 (dose, route of of administration, and anatomical location of administration was not reported) lot # M036059, expiration date: 03-JUN-2019 for prophylaxis. After the GARDASIL 9 vaccination, the patient laid down for 15 minutes and then was released to go from the office. It was reported that the patient left in his car, felt lightheaded and had a motor vehicle accident. The patient was taken by ambulance to to a hospital emergency room for evaluation and then was released. Unspecified treatment was given for the patient's lightheadedness. Laboratory diagnostic studies were not performed. The outcome of lightheaded was not provided. Causality assessment was not provided.  The Immunization Specialist has requested a lot check on the vaccine. Additional information has been requested.
Moderate shaking chills/ headache/ neck stiffness/ overall muscle pain/ temp of 100.3/spinal pain/ day 2-slight headache and muscle and neck pain/ Day 3- no remarkable symptoms Treatment-Rest Time -course above.
Vaccine expired on 13-Oct-2021 and then stored in refrigerator on 29-Oct-2021; dose was given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 13-Oct-2021 and then stored in refrigerator on 29-Oct-2021) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 13-Oct-2021 and then stored in refrigerator on 29-Oct-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 13-Oct-2021 and then stored in refrigerator on 29-Oct-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The reporter was infection control manager.  Concomitant medication of the patient was not reported.  There was no temperature excursion. The reporter reported that that there was a confusion between the expiration date printed in the carton and the expiration date when the QR code was scanned.  The patient did not experience any adverse event.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-491837 (Patient Link).
Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient was well during the 15 minute observation period and has no comorbidities according to health questionnaire. As she was exiting the store she felt faint and lost consciousness for 30 seconds and recovered consciousness. She fell backwards and bumped her head against the ground. Paramedics were called and patient BP and blood glucose was within normal limits. Patient was alert and sitting upright when paramedics arrived.
Pt received two Pfizer Covid vaccines in April 2021. She noted cough and fever and tested COVID positive as an outpatient on 12/13/21. She received monoclonal antibody therapy at the local HCF, on 12/15/21. However, her symptoms were not getting better, and she was admitted to another local hospital on 12/18/21. She was also tested Influenza A PCR positive and blood culture positive with Haemophilus influenzae DNA upon admission. She is still febrile but not on oxygen. Hospital Day 3, she is receiving Cetriaxone, Dexamethasone, Oseltamivir, and Remdesivir.
Began w/onset of temp (max 104.2 rectal) w/in 12 hrs of immunization. Emesis (vomit) x 2 and onset or urticaria w/in 24 hrs of immunizations.
On 1-10-14 pneumo was given. Patient noticed symptoms 1-11-14 rash and pain on injection site. Patient also has chest pain.
Pt recvd Engerix-B inadvertently by IV administration on 24SEP91; Reporter uncertain if was 1st, 2nd or 3rd Engerix-B; An IV line was in place @ time of administration; pt asymptomatic 1hr post vax & doing well; felt warm;
The patients arm immediately swelled at the injection site. She reports no itching. It looks like the amount was not absorbed into muscle, but under skin. Gave cold compress.
Onset of severe muscle and joint pain. Started tightness in neck. Then knees. Then hips and muscles. I took 400 acetaminophen at 10. Then 650mg at 130. 1 650mg at 5 then 1 250mg at 10pm. The next day i was fine
About 1 month after the 2nd dose vaccine, I had swollen right ankle, my right shoulder also felt tense, my right jaw has slight pain when I am opening and closing my mouth.  I also feel the area of my heart, a slight sharp pain that comes and goes. I also have buckling of both my knees.  I went to see my doctor,  They did a X-ray, CT scan,  and Venous duplex- everything came back normal and did not find anything, The doctor suggested I decrease salt intake.  As of now, I am still having intermitten swollen ankles and buckling of my legs, jaw pain and heart symptoms. I am using a air compression massager to increase the blood flow to the legs.
joint pain; Back stiffness; This is a spontaneous report from a contactable nurse (patient). This nurse reported events after first and second dose of the vaccine. This case is for events after the first dose. A 48-year-old female patient not pregnant received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Right on 29Jan2021 10:00 (Lot Number: EL9264) as single dose (at age of 48-year-old) for covid-19 immunisation. Medical history included non-hodgkin's lymphoma. The patient had no known allergies. Concomitant medications included st. john's wort (ST. JOHN'S WORT), fluoxetine hydrochloride (PROZAC), cyclobenzaprine hydrochloride (FLEXERIL [CYCLOBENZAPRINE HYDROCHLORIDE]), ergocalciferol (VITAMIN D [ERGOCALCIFEROL]). Patient did not receive any other vaccine in four weeks. On 29Jan2021 12:00 patient experienced joint pain all over with back stiffness. No treatment was received. Patient did not have COVID prior vaccination and also patient was not tested for COVID post vaccination. Patient had not recovered from the events, at the time of the report. Follow-up attempts completed. No further information expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021212605 same patient, same drug different dose, different event
Mild headache, started the same evening and lasting the next day. Stomach pain, sharp pain starting 1 week after vaccination lasting one day. *Ringing in both ears, starting 2 days after vaccination and still continuing.  Worse at night. Bruise and pain at injection site, starting the same evening and continuing for about 1 week.
Felt sick; Fever; Achiness; This case was reported by a consumer via call center representative and described the occurrence of feeling unwell in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2019-2020 season) for prophylaxis.   On 21st September 2019, the patient received the 1st dose of Shingrix (intramuscular) and Influenza vaccine Quadrivalent 2019-2020 season. On 21st September 2019, less than a day after receiving Shingrix and Influenza vaccine Quadrivalent 2019-2020 season, the patient experienced feeling unwell, fever and pain. On 22nd September 2019, the outcome of the feeling unwell, fever and pain were recovered/resolved.   It was unknown if the reporter considered the feeling unwell, fever and pain to be related to Shingrix and Influenza vaccine Quadrivalent 2019-2020 season.  Additional details were provided as follows: The patient received Shingrix on left upper arm and she also received the flu vaccine that same day.  The patient reported that after receiving both vaccines, she felt sick in the middle of the night, she had fever and achiness.  She said all symptoms were resolved and gone in the morning.  The patient was not sure if the Shingrix or the Flu vaccine caused those symptoms. The patient consented to follow up.
Large red patch, warm to touch, spanning about 4" in diameter at injection site. Patient does not complain of pain/itch.
Pt recv vax on 10/16/98; on 10/18/98 pt exp diarrhea, dizziness x 24 hr
the next day whole thigh was red & swollen, febrile 102 & thigh hot to touch lasted 1 1/2days;fever went away;swelling & redness slowly went down over 2wk;noted lump;got bigger bruised over weekend;
Carcinoma cancers removed from her face; Shingles outbreaks are worse; Shingles outbreaks are worse; This case was reported by a consumer via call center representative and described the occurrence of carcinoma in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles, open heart surgery, cancer and stent placement. Concomitant products included acyclovir and valaciclovir hydrochloride (Valacyclovir).   On 23rd October 2019, the patient received the 1st dose of Shingrix. On 27th February 2020, the dose was an unknown dose. In November 2019, 2 weeks after receiving Shingrix, the patient experienced shingles and condition aggravated. On an unknown date, the patient experienced carcinoma (serious criteria GSK medically significant). On an unknown date, the outcome of the carcinoma, shingles and condition aggravated were unknown.   It was unknown if the reporter considered the carcinoma, shingles and condition aggravated to be related to Shingrix.  Additional details were provided as follows: The patient received the vaccine in the top part of her arm.  The patient had a history of shingles but she claimed that her shingles outbreaks were worse after getting both doses of the Shingrix.  The shingles were on her behind.  After getting the 1st dose of Shingrix, two weeks later, the patient got shingles again and she had a shingles outbreak about 5 times since and they were worse than before.  The patient reported that, she would have gotten the second dose closer to the first dose but she had four carcinoma cancers removed from her face in December 2019. The patient also reported that, she had a stent put in on 04th November 2019 after having open heart surgery in 2017.  At the time of reporting, the patient was taking Acyclovir each night and used the Zovirax cream.  The reporter was consented to follow up. For the tolerance of 2nd dose, refer the linked case US2020AMR127486.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR127486:same patient
Patient is feeling like her chest hurts.  Mom says pulse was 130 at resting the other day.  She thinks the patient feels this about 3 to 4 times per week.  She has the patient rest  when these symptoms happen
Tingling; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Jun-2021 and was forwarded to Moderna on 23-Jun-2021.    This spontaneous case was reported by a non-health professional and describes the occurrence of PARAESTHESIA (Tingling) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On 22-Jun-2021, the patient experienced PARAESTHESIA (Tingling). At the time of the report, PARAESTHESIA (Tingling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment medications were not provided by the reporter. Action taken with mRNA-1273 in response to the events were not Applicable
10-15-08 7:00am feeling chills, fatigue, arm tender. 9:00am seen by nurse left upper arm warm & tender to touch, red & swollen area approx 6 X 8cm. Advised to take ibuprofen & place cool packs on red area. 10-17-08 Feeling almost normal with red/tender area resolving.
Skin pain; Sore arm; Hip pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An adult female patient (not pregnant) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) intramuscular for covid-19 immunisation. The patient's relevant medical history included: "COVID-19" (unspecified if ongoing), notes: the patient diagnosed with COVID-19 prior to vaccination. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, Manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (Dose 2, Manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (Dose 3, Manufacturer unknown), for COVID-19 immunization. The following information was reported: ARTHRALGIA (non-serious) with onset 08Oct2023, outcome "recovering", described as "Hip pain"; PAIN OF SKIN (non-serious) with onset 08Oct2023, outcome "recovering", described as "Skin pain"; PAIN IN EXTREMITY (non-serious) with onset 08Oct2023, outcome "recovering", described as "Sore arm". Therapeutic measures were not taken as a result of pain of skin, pain in extremity, arthralgia.  Additional information: The patient has not been tested for COVID-19 Since the vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Vaccine was administered beyond expiration date. Vaccine expiration date (10 weeks/refrigeration) was 01/11/2023, administer on 01/20/2023, 9 days past expiration.  Outcome: Per CDC, repeat dose in 8 weeks. Patient contacted, made aware and appointment scheduled to repeat dose.
Rash on site one week after vaccine. Swollen red bump. Feels hot to the touch. Rest of the arm feels cold. Tired, chills, stuffy nose, raspy voice.
SkinRash, Rash & UrticariaPruritus Narrative:  Employee reports developed a "rash and hives all over body" approximately 10 days after receiving first dose of vaccine. Reports went to the doctor and was given prednisone (no dose/frequency/duration provided). Has not fully recovered as of date of this report, per employee report.
This case was reported by a nurse via sales rep and described the occurrence of vomiting in a patient who received BEXSERO for prophylaxis. Co-suspect products included FLUARIX QUADRIVALENT 2018-2019 season for prophylaxis. On an unknown date, the patient received BEXSERO at an unknown dose and FLUARIX QUADRIVALENT 2018-2019 season at an unknown dose. On an unknown date, less than a year after receiving BEXSERO and FLUARIX QUADRIVALENT 2018-2019 season, the patient experienced vomiting, headache, dizziness and fever. On an unknown date, the outcome of the vomiting, headache, dizziness and fever were unknown. It was unknown if the reporter considered the vomiting, headache, dizziness and fever to be related to BEXSERO and FLUARIX QUADRIVALENT 2018-2019 season. Additional details were provided as follows: The age at vaccination was not reported. The nurse informed her GSK vaccine representative that the patient received both BEXSERO and FLUARIX at the same time and experienced heavy vomiting, fever, headache and dizziness. This case has been linked with US2018193568, reported by the same reporter.
Patient came to the pharmacy today 12/5 and said that he's having issues with his arm since his shot. He said he can not lift his right arm (flu shot arm) very well and has trouble scratching his back. It started a few days after he got the shot and he has seen the Dr since and started physical therapy for the arm. He thought that made he had some nerve damage from the vaccine. He did not know the exact date that his symptoms started.
Patient received the vaccine on 9/28 and reports waking up 2 to 3 days later with two large hard bumps on her left arm. The bumps have not resolved as of 10/12/23 and have remained the same in size and consistency throughout the two weeks.
tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (tired). At the time of the report, FATIGUE (tired) outcome was unknown.            No concomitant were reported.  No treatment were reported.   This case was linked to MOD-2021-352754 (Patient Link).
Moderna COVID-19 Vaccine EUA severe dizziness and vomiting beginning day after vaccine at 6pm.
Sore arm, body aches, fever (~102F), head ache; Sore arm, body aches, fever (~102F), head ache; Sore arm, body aches, fever (~102F), head ache; Sore arm, body aches, fever (~102F), head ache; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EP 6955 and expiry date was not reported), via an unspecified route of administration, in Arm Right, on 23Mar2021 at 12:15 PM (age at vaccination: 50 years), as a single dose for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient's medical history was not reported. The patient did not have any known allergies and allergies to medications, food, or other products. Concomitant medication included colecalciferol (VITAMIN D). Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL 3247 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 04Mar2021 at 01:15 PM (age at vaccination: 50 years), as a single dose for COVID-19 immunization. The patient was not diagnosed with COVID prior vaccination. The patient was not tested for COVID post vaccination. The patient did not receive any other vaccine in four weeks. On 24Mar2021 at 12:30 AM, the patient experienced sore arm, body aches, fever (~102F), headache. The patient did not received any treatment for the events. The patient underwent lab test and procedure included temperature with ~102F on 24Mar2021. Outcome of the events was recovering.  No follow-up attempts are needed. No further information is expected.
Vesicular lesions, on buttock, one lesion with conjunctivitis. Possible onset 7/18/2012 treated with mupirocin ointment outcome about 10 vesicular lesion at varying stage of healing.
Patient passed away on 4/25/2017. Did not talk to parents of child. Request for medical records came from Forensic Center on 4/25/2017 at 2:45 pm and that is when we found out the baby had died.
I was having body aches and chills. I was really tired and nasal congestion and running nose. I felt like I had a fever don't know how high it was. I took a home COVID test it was positive. doctor gave me Paxlovid.